You are on page 1of 33

Plipos Gstricos Revisin

Rolando Illescas Quiroz


HGUE Febrero 201

Plipo
!el "rie"o #pol$pus%& 'ue si"ni(ica #)uc*os pies%

+elsus (ue el pri)ero 'ue e)pleo esta palabra en )edicina al re(erirse a un plipo nasal,,

Plipo "strico
Qu- conducta se"uir ante un plipo "strico,,. +ul es el )ane/o inicial,,. +)o es el se"ui)iento0.

Gastric Polyps: A Review of Clinical, Endoscopic, and Histopathologic Features and Manage ent !ecisions"
Ra(iul 1a)eer Isla)& 2!& 234& 5eal +, Patel& 2!& !ora 6a)7Hi)lin& 2!& and +uon" +, 5"u$en& 2!Pub2ed ,
Gastroenterolo"$ 8 Hepatolo"$ 9olu)e :& Issue 10 ;ctober 201<,

Manage ent of Gastric Polyps: An Endoscopy#$ased Approach"


=411ERH 1H4I3& 2411I2; RUGGE& !49I! =, GR4H42& and R;3ER> 2 GE5>4,
+6I5I+46 G41>R;E5>ER;6;G= 45! HEP4>;6;G= 201<? 11@1<A B1<C

%he

anage ent of gastric polyps"


4ndreD F, Goddard& RaD$a 3adreldin& on be*al( o( t*e 3ritis* 1ociet$ o( Gastroenterolo"$,
Gut 2010?E:@ 12A0 e12AF

Manage ent of gastric polyps: a pathology#&ased guide for gastroenterologists"


1usanne G, +ar)acH& Robert 2, Genta& !avid =, Gra*a) and Gre"or$ =, 6auDers,
5at, Rev, Gastroenterol, Hepatol, F& <<1B< 1 I200:J

Plipos "stricos
Hiperplsico Glndulas (Kndicas >u)or de c-lulas "ranulares 6eio)io)a GI1> +oDden 1d, Poliposis /uvenil Pncreas ectpico Peutz7Le"*ers 4deno)atoso In(la)atorio& (ibroide 5euroendocrino "strico IcarcinoideJ

-1-6% de endoscopias altas. >90% asintomticos -Sintomticos: anemia, sangrado, obstruccin, dolor abdominal, los de mayor tamao. -La mayora no tienen riesgo de cncer. -Algunos con potencial maligno que deben ser vigilados. -Identificacin histolgica (epitelial, hamartomatosos, mesenquimal)

Gastroenterolo"$ 8 Hepatolo"$ 9olu)e :& Issue 10 ;ctober 201<

Gastroenterolo"$ 8 Hepatolo"$ 9olu)e :& Issue 10 ;ctober 201<

Gastric Polyps: A Review of Clinical, Endoscopic, and Histopathologic Features and Manage ent !ecisions

Gastroenterolo"$ 8 Hepatolo"$ 9olu)e :& Issue 10 ;ctober 201<

Gastroenterolo"$ 8 Hepatolo"$ 9olu)e :& Issue 10 ;ctober 201<

Plipo de "lndulas (Kndicas

Plipo *iperplsico

Plipo *iperplsico

Plipo 4deno)atoso

Plipo (ibroide in(la)atorio

GI1>

>u)or +arcinoide

Manto)a

Plipos Gstricos GuNa de )ane/o GU>,2010

>*e )ana"e)ent o( "astric pol$ps 1 4ndreD F, Godart, 75o toca el te)a de cancer "strico te)prano, 7!iri"ida a endoscopistas 72etodolo"Na GR4!E 7 Reco)endaciones de consenso E

<

Gut 2010?E:@ 12A0 712AF

10

Gut 2010?E:@ 12A0 712AF

4EG

4EG

Acid suppressive drugs and gastric cancer: A

eta#analysis of o&servational studies

World J Gastroenterol. 2013 April 28; 19(16): 25602568. Published online 2013 April . 8. doi: 10.3748/wjg.v19.i16.2560. PMCID: PMC3646149 Jeong Soo Ahn, Chun-Sick Eom, Christie Y Jeon, and Sang Min Park

Abstract AIM: To evaluate the association between acid suppressive drug use and the development of gastric cancer. METHODS: A systematic search of relevant studies that were published through June 2012 was conducted using the MEDLINE (PubMed), EMBASE, and Cochrane Library databases. The search included observational studies on the use of histamine 2-receptor antagonists (H2RAs) or proton pump inhibitors and the associated risk of gastric cancer, which was measured using the adjusted odds ratio (OR) or the relative risk and 95%CI. An independent extraction was performed by two of the authors, and a consensus was reached.

RESULTS: Of 4595 screened articles, 11 observational studies (n = 94558) with 5980 gastric cancer patients were included in the final analyses. When all the studies were pooled, acid suppressive drug use was associated with an increased risk of gastric cancer risk (adjusted OR = 1.42; 95%CI: 1.291.56, I2 = 48.9%, P = 0.034). The overall risk of gastric cancer increased among H2RA users (adjusted OR = 1.40; 95%CI: 1.24-1.59, I2 = 59.5%, P = 0.008) and PPI users (adjusted OR = 1.39; 95%CI: 1.19-1.64, I2 = 0.0%, P = 0.377). CONCLUSION: Acid suppressive drugs are associated with an increased risk of gastric cancer. Further studies are needed to test the effect of acid suppressive drugs on gastric cancer. Keywords: H2-receptor antagonists, Proton pump inhibitors, Gastric cancer, Meta-analysis

FNn

You might also like